Shopping Cart is Empty..

$ 0

Blood and Organ Bank Market by Product (Red Blood Cell Collection, Processing, and Distribution Services, Blood Plasma Collection, Processing, and Distribution Services, Organ Bank Services, Tissue Bank Services, Health Screening Services, All Other Human Blood Service and Reproductive and Stem Cell Bank Services), by Activity (Collecting Blood, Storing Blood, Distributing Blood, Storing Organs, Distributing Organs, Research and Storage Technology and Reproductive Tissue), and by End-User (Hospitals, Diagnostics Centers, Blood Bank and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Medical Devices & Supplies	LI 173355	Pages: NA	Formats*:
Oct 2017 \| 93 Views	Charts: NA	Tables: NA	Author(s): NA

The blood bank is a place where blood and plasma samples are stored for the transfusion process. Blood transfusion is needed in the case of accidental emergency or blood loss disorders such as thalassemia, sickle cell anemia, blood cancer, and anemia. The organ bank is similar to blood banks that stores body organs for organ transplantation. Organ transplantation is a process of surgically replacing diseased or failed organs with another organ.

Factors such as the rising prevalence of hematological diseases such as thalassemia, sickle cell anemia, blood cancer, and anemia, increasing accidental cases, and rising geriatric population drive the market growth. In addition, increase in the awareness of the population, along with rising biotechnological research and development studies fuel the growth of this market. However, post-operative complications such as allergic reactions, fever, acute hemolytic reaction, blood borne infection, and arthritis are expected to restrain the market growth. Blood transfusion and organ transplantation in emerging nations are anticipated to create new opportunities during the forecast period

The blood and organ bank market is segmented based on product, activity, end-user, and geography. By product, it is categorized into red blood cell collection, processing, distribution services, blood plasma collection, processing, distribution services, organ bank services, tissue bank services, health screening services, all other human blood services, and reproductive & stem cell bank services. By activity the market is segmented into collecting blood, storing blood, distributing blood, storing organs, distributing organs, research & storage technologies, and reproductive tissues. By end-user the market is categorized into hospitals, diagnostics centers, blood bank, and others. Geographically, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

The study provides an in-depth analysis of the blood and organ bank market, with current trends and future estimations to elucidate investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
The report offers a quantitative analysis to help stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments determines various products available in the market.
Key players have been profiled and their strategies thoroughly analyzed to predict the competitive market outlook.

Blood And Organ Bank Market Key Segments:

By Product

Red Blood Cell Collection, Processing, and Distribution Services
Blood Plasma Collection, Processing, and Distribution Services
Organ Bank Services
Tissue Bank Services
Health Screening Services
All Other Human Blood Services
Reproductive and Stem Cell Bank Services

By Activity

Collecting Blood
Storing Blood
Distributing Blood
Storing Organs
Distributing Organs
Researching Storage Technologies
Reproducing Tissues

By End-User

Hospitals
Diagnostic Canters
Blood Banks
Others

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
LAMEA
- Latin America
- The Middle East
- Africa

List of players profiled in the report

American Red Cross
New England Organ Bank
21st Century Medicine
New York Blood Centre
The Living Bank
Musculoskeletal Transplant Foundation, Inc.
National Organ & Tissue Transplant Organisation
China Cord Blood Corporation
New York Cord Blood Program
Cord Blood Registry

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

License Type

Data Pack

Single User PDF

Five User Online/PDF

Enterprise Online/PDF

LICENSE INFO

Users/Sharing

Restricted to one authorized user

Limited to 5 authorized users

Unlimited within company / enterprise

Printing

One Print only

Up to Five Copies

Unlimited within company / enterprise

Delivery Formats

ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

Have questions ?
Speak with analyst

Did you miss anything?
To add more

* Taxes/Fees, If applicable, will be
added at the checkout. All prices in USD.

Need More Information

+1-503-894-6022

help@alliedmarketresearch.com

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to eliminate redundant information to provide valued information and save time of the reader

Get fresh content delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

Report Title: Blood and Organ Bank Market by Product (Red Blood Cell Collection, Processing, and Distribution Services, Blood Plasma Collection, Processing, and Distribution Services, Organ Bank Services, Tissue Bank Services, Health Screening Services, All Other Human Blood Service and Reproductive and Stem Cell Bank Services), by Activity (Collecting Blood, Storing Blood, Distributing Blood, Storing Organs, Distributing Organs, Research and Storage Technology and Reproductive Tissue), and by End-User (Hospitals, Diagnostics Centers, Blood Bank and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Select Chapters

Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8

Full Name: *:

Company Name: *:

Job Role: *:

Email: *:

Country: *:

Contact Number: *:

How can we help? *:

Security Code: *:

STAY WITH US

WE ACCEPT

* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com
Chapter: 1 INTRODUCTION 1.1. REPORT DESCRIPTION 1.2. KEY BENEFITS 1.3. KEY MARKET SEGMENTS 1.4. RESEARCH METHODOLOGY 1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools & models
Chapter: 2 EXECUTIVE SUMMARY 2.1. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW 3.1. MARKET DEFINITION AND SCOPE 3.2. KEY FINDINGS 3.2.1. Top investment pockets 3.2.2. Top winning strategies 3.3. MARKET SHARE ANALYSIS, 2016 3.4. PORTER’S FIVE FORCES ANALYSIS 3.4.1. MARKET DYNAMICS 3.4.2. Drivers 3.4.3. Restraints 3.4.4. Opportunities
Chapter: 4 BLOOD AND ORGAN BANK MARKET, BY PRODUCT 4.1. OVERVIEW 4.1.1. Market size and forecast 4.2. RED BLOOD CELL COLLECTION, PROCESSING, AND DISTRIBUTION SERVICES 4.2.1. Key market trends 4.2.2. Growth factors and opportunities 4.2.3. Market size and forecast 4.3. BLOOD PLASMA COLLECTION, PROCESSING, AND DISTRIBUTION SERVICES 4.3.1. Key market trends 4.3.2. Growth factors and opportunities 4.3.3. Market size and forecast 4.4. ORGAN BANK SERVICES 4.4.1. Key market trends 4.4.2. Growth factors and opportunities 4.4.3. Market size and forecast 4.5. TISSUE BANK SERVICES 4.5.1. Key market trends 4.5.2. Growth factors and opportunities 4.5.3. Market size and forecast 4.6. HEALTH SCREENING SERVICES 4.6.1. Key market trends 4.6.2. Growth factors and opportunities 4.6.3. Market size and forecast 4.7. ALL OTHER HUMAN BLOOD SERVICES 4.7.1. Key market trends 4.7.2. Growth factors and opportunities 4.7.3. Market size and forecast 4.8. REPRODUCTIVE AND STEM CELL BANK SERVICES 4.8.1. Key market trends 4.8.2. Growth factors and opportunities 4.8.3. Market size and forecast
Chapter: 5 BLOOD AND ORGAN BANK MARKET, BY ACTIVITY 5.1. OVERVIEW 5.1.1. Market size and forecast 5.2. COLLECTING BLOOD 5.2.1. Market size and forecast 5.3. STORING BLOOD 5.3.1. Market size and forecast 5.4. DISTRIBUTING BLOOD 5.4.1. Market size and forecast 5.5. STORING ORGAN 5.5.1. Market size and forecast 5.6. DISTRIBUTING ORGANS 5.6.1. Market size and forecast 5.7. RESEARCHING STORAGE TECHNOLOGIES 5.7.1. Market size and forecast 5.8. REPRODUCING TISSUES 5.8.1. Market size and forecast
Chapter: 6 BLOOD AND ORGAN BANK MARKET, BY END-USER 6.1. OVERVIEW 6.1.1. Market size and forecast 6.2. HOSPITAL 6.2.1. Market size and forecast 6.3. DIAGNOSTIC CANTERS 6.3.1. Market size and forecast 6.4. BLOOD BANKS 6.4.1. Market size and forecast 6.5. OTHERS 6.5.1. Market size and forecast
Chapter: 7 BLOOD AND ORGAN BANK MARKET, BY REGION 7.1. OVERVIEW 7.2. NORTH AMERICA 7.2.1. Key market trends 7.2.2. Key growth factors and opportunities 7.2.3. Market size and forecast 7.2.3.1. U.S. market size and forecast 7.2.3.2. Canada market size and forecast 7.2.3.3. Mexico market size and forecast 7.2.4. North America Blood and Organ Bank Market by Product 7.2.5. North America Blood and Organ Bank Market by Activity 7.2.6. North America Blood and Organ Bank Market by End-Uesre 7.3. EUROPE 7.3.1. Key market trends 7.3.2. Key growth factors and opportunities 7.3.3. Market size and forecast 7.3.3.1. UK market size and forecast 7.3.3.2. Germany market size and forecast 7.3.3.3. France market size and forecast 7.3.3.4. Spain market size and forecast 7.3.3.5. Italy market size and forecast 7.3.3.6. Rest of Europe market size and forecast 7.3.4. Europe Blood and Organ Bank Market by Product 7.3.5. Europe Blood and Organ Bank Market by Activity 7.3.6. Europe Blood and Organ Bank Market by End-User 7.4. ASIA-PACIFIC 7.4.1. Key market trends 7.4.2. Key growth factors and opportunities 7.4.3. Market size and forecast 7.4.3.1. China market size and forecast 7.4.3.2. Japan market size and forecast 7.4.3.3. India market size and forecast 7.4.3.4. Rest of Asia-Pacific market size and forecast 7.4.4. Asia-Pacific Blood and Organ Bank Market by Product 7.4.5. Asia-Pacific Blood and Organ Bank Market by Activity 7.4.6. Asia-Pacific Blood and Organ Bank Market by End-User 7.5. LAMEA 7.5.1. Key market trends 7.5.2. Key growth factors and opportunities 7.5.3. Market size and forecast 7.5.3.1. Latin America market size and forecast 7.5.3.2. The Middle East market size and forecast 7.5.3.3. Africa market size and forecast 7.5.4. LAMEA Blood and Organ Bank Market by Product 7.5.5. LAMEA Blood and Organ Bank Market by Activity 7.5.6. LAMEA Blood and Organ Bank Market by End-USer
Chapter: 8 COMPANY PROFILES 8.1. AMERICAN RED CROSS 8.1.1. Operating business segments 8.1.2. Business performance 8.1.3. Key strategic moves and developments 8.2. NEW ENGLAND ORGAN BANK 8.2.1. Operating business segments 8.2.2. Business performance 8.2.3. Key strategic moves and developments 8.3. 21ST CENTURY MEDICINE 8.3.1. Operating business segments 8.3.2. Business performance 8.3.3. Key strategic moves and developments 8.4. NEW YORK BLOOD CENTRE 8.4.1. Operating business segments 8.4.2. Business performance 8.4.3. Key strategic moves and developments 8.5. THE LIVING BANK 8.5.1. Operating business segments 8.5.2. Business performance 8.5.3. Key strategic moves and developments 8.6. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. 8.6.1. Operating business segments 8.6.2. Business performance 8.6.3. Key strategic moves and developments 8.7. NATIONAL ORGAN & TISSUE TRANSPLANT ORGANISATION 8.7.1. Operating business segments 8.7.2. Business performance 8.7.3. Key strategic moves and developments 8.8. CHINA CORD BLOOD CORPORATION 8.8.1. Operating business segments 8.8.2. Business performance 8.8.3. Key strategic moves and developments 8.9. NEW YORK CORD BLOOD PROGRAM 8.9.1. Operating business segments 8.9.2. Business performance 8.9.3. Key strategic moves and developments 8.10. CORD BLOOD REGISTRY 8.10.1. Operating business segments 8.10.2. Business performance 8.10.3. Key strategic moves and developments

Purchase Options